MAP Pharmaceuticals, Inc.

• About Us 
  • Message from the CEO
  • Management Team
  • Board of Directors
  • Partnering
  • Contact Us
• Product Pipeline 
  • Migraine
  • Pediatric Asthma
  • Asthma/COPD
  • Diabetes
• Investor Relations 
  • IR Home
  • Press Releases
  • Events and Presentations
  • Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • Annual Reports
  • SEC Filings
  • Stock Information
  • Analyst Coverage
  • Contact Us
• Science & Technology 
• Publications 
  • Migraine
  • Asthma
  • Aerosol Science & Technology

Investor Relations

Print page     Email page

SEC Filings

View: All Filings Annual Quarterly Current Section 16 Proxy Other    Year: All Years 2010 2009 2008 2007

Filing	Description	Date Filed	Size
4	pearl, frank h	Mar 10, 2010	27.1 KB
4	sfm, participation lp	Mar 10, 2010	25.7 KB
4	soros, george	Mar 10, 2010	29.7 KB
S-3/A	registration statement	Mar 9, 2010	216.6 KB
10-K/A	amended annual report	Mar 9, 2010	939.4 KB
4	soros, george	Mar 8, 2010	31.9 KB
4	sfm, participation lp	Mar 8, 2010	27.2 KB
4	perseus, soros partners llc	Mar 8, 2010	24.1 KB
4	pearl, frank h	Mar 8, 2010	29.7 KB
4	perseus, biotech fund partners llc	Mar 8, 2010	26.6 KB
10-K	annual report	Mar 5, 2010	1.0 MB
4	gianakakos, anastasios	Mar 3, 2010	21.2 KB
4	nelson, timothy s	Mar 3, 2010	21.2 KB
8-K	current report	Mar 2, 2010	57.5 KB
4	perseus, biotech fund partners llc	Feb 24, 2010	24.1 KB
4	pearl, frank h	Feb 24, 2010	25.7 KB
4	soros, george	Feb 24, 2010	26.1 KB
4	elms, steve	Feb 24, 2010	19.2 KB
4/A	soros george	Feb 18, 2010	26.8 KB
4	elms, steve	Feb 16, 2010	19.6 KB
Showing 1-20 of 237 Page: 1 2 3 ... 12  Next 20

= add filing to Briefcase

Stock Information

NASDAQ:MAPP $16.19	+ 0.02
Mar 11, 2010	3:15 PM ET

Quotes delayed at least 20 minutes.
Information provided by eSignal.